Institut de Recherche en Sciences de la Sante, Burkina Faso
Quick facts
Marketed products
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Institut de Recherche en Sciences de la Sante, Burkina Faso portfolio CI brief
- Institut de Recherche en Sciences de la Sante, Burkina Faso pipeline updates RSS
Frequently asked questions about Institut de Recherche en Sciences de la Sante, Burkina Faso
What are Institut de Recherche en Sciences de la Sante, Burkina Faso's marketed drugs?
Top marketed products include Amodiaquine Sulfadoxine-Pyrimethamin administration.